Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features
about
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesMolecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.Primary peritoneal carcinoma: regional cancer institute experienceRelationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobinMixed apocrine/endocrine ductal carcinoma in situ of the breast coexistent with lobular carcinoma in situ.An effect of letrozole on gastric cancer?GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review.ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.Apocrine carcinoma of the breast. A morphologic and immunocytochemical study.The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epitheliumCell-Specific Cre Strains For Genetic Manipulation in Salivary GlandsBreast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature.Is apocrine differentiation in breast carcinoma of prognostic significance?Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumoursA Rapidly Enlarging Squamous Inclusion Cyst in an Axillary Lymph Node following Core Needle Biopsy.Non-operative breast pathology: apocrine lesions.The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.Atypical breasts cancersProlactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients.Uroplakin II Expression in Breast Carcinomas Showing Apocrine Differentiation: Putting Some Emphasis on Invasive Pleomorphic Lobular Carcinoma as a Potential Mimic of Urothelial Carcinoma at Metastatic Sites.Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis.Diagnosis and surgical resection of solitary pulmonary nodules in patients with breast cancer.Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohortCharacterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.Small bowel obstruction from distant metastasis of primary breast cancer: a case report.
P2860
Q34006749-4C6C975B-F2B9-44B9-BC57-759A61119090Q34173563-322AF01D-5292-4F2E-8F9A-46A802BEEA4BQ34534359-A72ABAC0-950D-4E34-987F-B51F063D5168Q35155568-A9DD01CC-B93D-4B18-A3AA-4C3B9C5D9654Q35397357-BED4E4B9-4D51-46D9-AF57-D3CD5F42E212Q35480777-B26FB4BC-2DB1-4C19-B461-D8B8639F2F87Q35617535-5A4F3215-03B0-4A39-BC48-023489CA6851Q35811176-B212291B-C50F-47EB-B20B-3289D9CD6DE9Q35818905-463C7C39-4AC6-461F-9A35-0DB9EEC67EAFQ35836033-3E9CCDFF-4F94-4532-A251-B13527F66FEBQ35858409-1273077C-536F-4794-A25C-4D80AF681349Q35890157-753FDE19-6895-4311-AACF-C36C4EF74415Q35920352-E088DE64-47EF-4AFA-B414-5498B81FA203Q35982863-4892FD1B-5F5D-4FEB-B5D1-9D162A38B7D0Q36115207-FEBFBBF0-31AE-413B-BFF5-D5A476A27A50Q36169354-3631C3FF-D976-4797-8589-470E9882D2FFQ36172494-5C04CF89-5D84-46FF-95DA-997C45D7DC60Q36619927-562518B7-29FD-49A7-9CB8-AFDEB0B1E286Q36758092-426FDEC5-BBF5-4531-BD68-47B129F0B449Q36958351-AC6CB116-169E-49ED-9CC4-519CDF0BE7E8Q37232372-24F6A296-7571-41F3-A1EC-72D655F5D70DQ37466285-72DB2667-A9BA-471B-8078-5098CA2A257EQ37641060-C919575A-7AD9-4E04-93DD-FF7A87CB9F0AQ41130064-F5B2ABEE-6D68-4FD1-AAA3-922B3A750CD7Q41251750-8899FB73-744D-45E1-BC2F-67E5428F327DQ49578351-AC4A7878-2524-4F2B-9035-E728F0F3A054Q50021339-8CD4215E-C8C9-419D-B41D-07C7847888AA
P2860
Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features
description
1983 nî lūn-bûn
@nan
1983 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Immunohistochemistry of a gros ...... cinomas with apocrine features
@ast
Immunohistochemistry of a gros ...... cinomas with apocrine features
@en
Immunohistochemistry of a gros ...... cinomas with apocrine features
@nl
type
label
Immunohistochemistry of a gros ...... cinomas with apocrine features
@ast
Immunohistochemistry of a gros ...... cinomas with apocrine features
@en
Immunohistochemistry of a gros ...... cinomas with apocrine features
@nl
prefLabel
Immunohistochemistry of a gros ...... cinomas with apocrine features
@ast
Immunohistochemistry of a gros ...... cinomas with apocrine features
@en
Immunohistochemistry of a gros ...... cinomas with apocrine features
@nl
P2093
P2860
P3181
P1476
Immunohistochemistry of a gros ...... cinomas with apocrine features
@en
P2093
D E Haagensen
G Mazoujian
G S Pinkus
P2860
P304
P3181
P407
P577
1983-02-01T00:00:00Z